Lessee, Operating Lease, Liability, Undiscounted Excess Amount of Can-Fite BioPharma Ltd. from 31 Dec 2023 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
Summary
Can-Fite BioPharma Ltd. quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount in USD history and change rate from 31 Dec 2023 to 31 Dec 2024.
  • Can-Fite BioPharma Ltd. Lessee, Operating Lease, Liability, Undiscounted Excess Amount for the quarter ending 31 Dec 2024 was $29,000, a 1350% increase year-over-year.
Source SEC data
View on sec.gov
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, Quarterly (USD)
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, YoY Quarterly Change (%)

Can-Fite BioPharma Ltd. Quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $29,000 +$27,000 +1350% 31 Dec 2024 20-F 14 Apr 2025 2024 FY
Q4 2023 $2,000 31 Dec 2023 20-F 28 Mar 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.